D
BioVaxys Technology Corp. BIOV
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

07/31/2024 04/30/2024 01/31/2024 10/31/2023 07/31/2023
Net Income -3.58M -4.83M -5.53M -6.63M -10.35M
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 2.02M 2.66M 3.38M 4.08M 8.27M
Change in Net Operating Assets 940.80K 1.83M 1.61M 1.77M 1.14M
Cash from Operations -622.70K -339.50K -543.00K -780.20K -935.80K
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -778.50K -778.50K -- -- --
Cash from Investing -778.50K -778.50K -- -- --
Total Debt Issued 13.80K -- -- -- --
Total Debt Repaid -33.40K -33.40K -- -- --
Issuance of Common Stock 2.41M 1.68M 1.63M 917.10K 1.27M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- -25.30K
Cash from Financing 1.76M 1.22M 1.21M 678.00K 924.90K
Foreign Exchange rate Adjustments 1.10K -2.00K -3.00K -2.40K -16.90K
Miscellaneous Cash Flow Adjustments 0.00 0.00 0.00 0.00 --
Net Change in Cash 362.80K 100.00K 661.70K -104.50K -27.60K
Weiss Ratings